Congratulations, @Danrenick1 for being named as one of PM360 Magazine's "Transformational Leaders" ow.ly/imet30kg2K2

PHE's Snider Presents New CAR T-cell Study at ASCO: CAR T-cell Therapy Benefit Dependent on Prompt Treatment ow.ly/Gh8D30kyqpO #ASCO2018 #Oncology

Is OCM Episode-Based Spending Associated with Patient Outcomes? PHE's Baumgardner shares data from new study: ow.ly/jzWF30kz47e #OCM #Oncology #JMCP

PHE's Snider: Universal Purchase (UP) programs in US states have been ineffective at raising vaccine uptake. ow.ly/GNf830kztVL

Open-Source Tools for Value Assessment: A Promising Approach @PHEconomics buff.ly/2IlQj9c

Don’t miss our upcoming webinar on patient-centered research: “The Science of Dialogue: Patient-Centered Value Assessment” on July 25 at 10:00 AM PT by Suepattra May-Slater, a medical anthropologist, and Katharine Batt, an oncologist/hematologist. ow.ly/Ayjr30kUj9M

Precision Value & Health has been ranked #6 in MM&M magazine’s 2018 Agency Top 100 list. ow.ly/xiTW30kWJOq

Are you leveraging patient-centered research to understand the full value of innovative treatments? Register today for our upcoming webinar "The Science of Dialogue: Patient-centered Value Assessment" this Wednesday, July 25. ow.ly/7i5X30l4Eb3

How will new treatments improve population health? Join PHE's experts for our free, live 1hr webinar on 10/25 at 11:00am PT: ow.ly/NiXh30mf95Q

A new PHE-led study estimates the global cost of the 2013-2016 West Africa Ebola crisis exceeds previous estimates by $20 billion. Find out why. ow.ly/jbWI30mkF6g

ICYMI: The #Ebola virus epidemic in West Africa cost approximately $53.19 billion dollars, according to newly published study findings. Read more: bit.ly/2yp0xn0@IDSAIn… HIV Medicine Association @PHEconomics

Data size does matter. Read how small data is the next-generation data management system for biopharma. ow.ly/vOa530mtDkc

What does your schedule look like for #ISPOREU? You don't want to miss these sessions with our experts! You can also connect with them at booth 311!

Is CAR-T Therapy Comparable to Past Innovative Therapies in Regard to Health Outcomes, Cost-Effectiveness? An interview with James Baumgardner, PhD, of @PHEconomics buff.ly/2RIl2Ts

#CARTcell therapy cost-effective compared with past treatments #ASH18 @PHEconomics bit.ly/2LjRdpV

AJMC Podcast: PHE's Senior Research Economist Dr. James Baumgardner (ex-CBO) discusses his recently published study on cost variation to identify savings under the OCM. ow.ly/cJ2f30n3WmR

Are ICER's budget impact models accurate? You may be surprised by the answer. A new study published in Value in Health by PHE's Julia Snider, Jesse Sussell, Mahlet Tebeka, Alicia Gonzalez & scientific advisor Peter Neumann examine this question. ow.ly/ny6E30n3WoP

This one is close to my heart...my mom had lung CA. New therapies extended her life...for the birth of her 1st grandchild…my sister's HS graduation…and my doctoral graduation. Thanks The Center for Innovation and Value Research LUNGevity Foundation for incorporating the #patient voice into #value models #innovation

What do value assessments miss? Register for the free, one-hour live webinar on March 13th at 1:30pm ET, led by Harvard’s Dr. Anupam Jena, MD, PhD. #valueassessments #healtheconomics #healthcare ow.ly/JByy30nNyeH

Day 2 of #ISPORBaltimore is not over yet! We invite you and your colleagues to the Watertable Ground Floor Lounge at the Renaissance Baltimore Harborplace Hotel tonight - starting at 7:30 p.m. Join us for an evening of eating, drinking, socializing and a special performance!